Brief: Dermapharm Confirms 2026 Guidance
26/06/2026 12:33
BRIEF-Dermapharm Confirms 2026 Guidance June 26 (Reuters) - Dermapharm Holding SE DMPG.DE:
DERMAPHARM HOLDING SE - CONFIRMS 2026 GUIDANCE FOR CONSOLIDATED REVENUE OF EUR 1182-1218 MILLION
Source text: ID:nEQ4f4V5Fa
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))